Molecular markers of brain cholesterol homeostasis are unchanged despite a smaller brain mass in a mouse model of cholesteryl ester storage disease
- 7 October 2021
- Vol. 57 (1), 3-16
- https://doi.org/10.1002/lipd.12325
Abstract
Lysosomal acid lipase (LAL), encoded by the gene LIPA, facilitates the intracellular processing of lipids by hydrolyzing cholesteryl esters and triacylglycerols present in newly internalized lipoproteins. Loss-of-function mutations in LIPA result in cholesteryl ester storage disease (CESD) or Wolman disease when mutations cause complete loss of LAL activity. Although the phenotype of a mouse CESD model has been extensively characterized, there has not been a focus on the brain at different stages of disease progression. In the current studies, whole-brain mass and the concentrations of cholesterol in both the esterified (EC) and unesterified (UC) fractions were measured in Lal−/− and matching Lal+/+ mice (FVB-N strain) at ages ranging from 14 up to 280 days after birth. Compared to Lal+/+controls at 50, 68–76, 140–142, and 230–280 days of age, Lal−/− mice had brain weights that averaged approximately 6%, 7%, 18%, and 20% less, respectively. Brain EC levels were higher in the Lal−/− mice at every age, being elevated 27-fold at 230–280 days. Brain UC concentrations did not show a genotypic difference at any age. The elevated brain EC levels in the Lal−/− mice did not reflect EC in residual blood. An mRNA expression analysis for an array of genes involved in the synthesis, catabolism, storage, and transport of cholesterol in the brains of 141-day old mice did not detect any genotypic differences although the relative mRNA levels for several markers of inflammation were moderately elevated in the Lal−/− mice. The possible sites of EC accretion in the central nervous system are discussed.Keywords
Funding Information
- National Heart, Lung, and Blood Institute (R01HL009610)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK078592)
This publication has 83 references indexed in Scilit:
- Cholesterol homeostasis: a key to prevent or slow down neurodegenerationFrontiers in Physiology, 2013
- Dysregulation of cholesterol balance in the brain: contribution to neurodegenerative diseasesDisease Models & Mechanisms, 2012
- Unesterified Cholesterol Accumulation in Late Endosomes/Lysosomes Causes Neurodegeneration and Is Prevented by Driving Cholesterol Export from This CompartmentJournal of Neuroscience, 2011
- Multiple mechanisms limit the accumulation of unesterified cholesterol in the small intestine of mice deficient in both ACAT2 and ABCA1American Journal of Physiology-Gastrointestinal and Liver Physiology, 2010
- Cyclodextrin overcomes the transport defect in nearly every organ of NPC1 mice leading to excretion of sequestered cholesterol as bile acidJournal of Lipid Research, 2010
- ACAT1 gene ablation increases 24(S)-hydroxycholesterol content in the brain and ameliorates amyloid pathology in mice with ADProceedings of the National Academy of Sciences of the United States of America, 2010
- Structure of N-Terminal Domain of NPC1 Reveals Distinct Subdomains for Binding and Transfer of CholesterolCell, 2009
- LCAT synthesized by primary astrocytes esterifies cholesterol on glia-derived lipoproteinsJournal of Lipid Research, 2009
- Reversal of defective lysosomal transport in NPC disease ameliorates liver dysfunction and neurodegeneration in the npc1 −/− mouseProceedings of the National Academy of Sciences of the United States of America, 2009
- Wolman disease/cholesteryl ester storage disease: efficacy of plant-produced human lysosomal acid lipase in miceJournal of Lipid Research, 2008